| Gene symbol | CD22 | Synonyms | SIGLEC-2, SIGLEC2 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD22 molecule | ||||
| GTO ID | GTC1655 |
| Trial ID | NCT02935153 |
| Disease | Leukemia | Lymphoma |
| Altered gene | CD22 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD22 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies |
| Year | 2016 |
| Country | China |
| Company sponsor | Southwest Hospital, China |
| Other ID(s) | TMMU-BTC-007 |
| Cohort 1 | |||||||||
|
|||||||||